Welcome to LookChem.com Sign In|Join Free

CAS

  • or

204503-25-3

Post Buying Request

204503-25-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204503-25-3 Usage

Physical state

Colorless liquid
1-bromo-4-[(3-methylbut-2-en-1-yl)oxy]benzene is a liquid at room temperature and is colorless in appearance.

Molecular structure

Benzene ring with a bromine atom at the 1 position and a 3-methylbut-2-en-1-yl group attached to the 4 position through an oxygen atom
The compound's structure consists of a benzene ring, which is a six-carbon ring with alternating single and double bonds. A bromine atom is attached to the first carbon of the ring, and a 3-methylbut-2-en-1-yl group (an allyl group with a methyl group) is connected to the fourth carbon through an oxygen atom, forming an ether linkage.

Functional groups

Bromine atom, allyl group, and ether linkage
The presence of these functional groups contributes to the compound's reactivity and its use as an intermediate in organic synthesis.

Applications

Intermediate in the synthesis of pharmaceuticals and other organic compounds
Due to its unique chemical structure, 1-bromo-4-[(3-methylbut-2-en-1-yl)oxy]benzene is used as a building block in the production of various pharmaceuticals and other organic compounds.

Synonyms

p-bromoallyloxybenzene and p-bromoallyl phenyl ether
The compound is also known by these alternative names, which describe its structure and functional groups.

Reactivity

Useful in various organic synthesis processes
The compound's unique structure and functional groups make it a versatile intermediate for use in a range of organic synthesis reactions.

Hazards

Potential health and environmental risks
As with many organic compounds, 1-bromo-4-[(3-methylbut-2-en-1-yl)oxy]benzene may pose certain health and environmental risks, and proper handling and disposal procedures should be followed.

Check Digit Verification of cas no

The CAS Registry Mumber 204503-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,5,0 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 204503-25:
(8*2)+(7*0)+(6*4)+(5*5)+(4*0)+(3*3)+(2*2)+(1*5)=83
83 % 10 = 3
So 204503-25-3 is a valid CAS Registry Number.

204503-25-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-bromo-4-(3-methylbut-2-enoxy)benzene

1.2 Other means of identification

Product number -
Other names 4-bromophenyl 3-methylbut-2-en-1-ylether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:204503-25-3 SDS

204503-25-3Relevant articles and documents

MAP4K4 INHIBITORS

-

Paragraph 00266, (2020/07/05)

This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):

MAP4K4 INHIBITORS

-

Paragraph 00198, (2019/05/02)

This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, f

N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

-

Paragraph 000278, (2015/05/19)

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 204503-25-3